Image

Global Contraceptive Devices Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Contraceptive Devices Market, By Product Type (Male Contraceptive Devices, Female Contraceptive Devices), Technology (Hormonal Contraceptives, Barrier Contraceptives), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, Others)-Industry Trends and Forecast to 2029.

Contraceptive Devices Market

Market Analysis and Size

According to the World Health Organization, roughly 214 million women of reproductive age in developing countries wished to prevent pregnancy in July 2020. According to the same report, nearly half of all pregnancies were confirmed to be unplanned between 2015 and 2019. As a result of the rise in undesired pregnancies, there is a significant demand for contraceptive devices, which will drive the market even higher.

Female contraceptive devices are likely to have the highest share in the due to the availability of a broad variety of female contraceptive devices such as diaphragms, intrauterine devices, subdermal implants, vaginal rings, and others Devices type of devices sector. Data Bridge Market Research analyses that the contraceptive devices market was valued at USD 9023.02 million in 2021 and is further estimated to reach USD 14933.06 million by 2029, and is expected to grow at a CAGR of 6.50% during the forecast period of 2022 to 2029.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Male Contraceptive Devices, Female Contraceptive Devices), Technology (Hormonal Contraceptives, Barrier Contraceptives), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, Others), End (Hospitals, Clinics and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Bayer AG (Germany), Pfizer Inc. (US), Janssen Global Services, LLC (US), Teva Pharmaceutical Industries Ltd. (Jerusalem), Merck Sharp & Dohme Corp. (US), Mylan N.V. (US), Reckitt Benckiser Group plc. (UK), Veru Inc. (US), Medisafe Distribution Inc. (Canada), CooperSurgical, Inc. (US), Devex (US), Mayer Laboratories, Inc. (US), Allergan plc (Ireland), Agile Therapeutics (US), HLL Lifecare (India), ANSELL LTD (Australia), Mankind Pharma (India), TTK HealthCare (India), Boehringer Ingelheim International GmbH. (Austria), V-Care Pharma Pvt. Ltd. (India), VARDHAMAN LIFECARE PVT LTD (India), and Cipla Inc. (US)

Market Opportunities

  • The rise in the allowance for contraceptive devices on a regular basis
  • Rising healthcare expenditures
  • Technical advancements.
  • Rising initiatives as well as assistance from various NGOs

Market Definition

Contraceptive devices include medical devices, medicines, and surgical treatments that are used to prevent pregnancy. It also works to keep sexually transmitted illnesses at bay (STDs). It might be temporary or permanent, and both men and women could benefit from it. Sterilization for men and women is a permanent procedure, whereas hormonal and non-hormonal procedures are only temporary.

Contraceptive Devices Market Dynamics                                        

Drivers

  • Rise in the number of unwanted pregnancies

According to the Centers for Disease Control and Prevention, unplanned pregnancy accounts for around 37% of all births in the United States.

  • Growing awareness regarding sexually transmitted diseases (STDs)

Rise in the knowledge of sexually transmitted diseases (STDs), including gonorrhea, chlamydia, trichomoniasis, hepatitis B and HIV/AIDS.

  • Initiatives by governments

Various developed and developing country governments are also launching initiatives to raise awareness and encourage the use of effective contraceptive devices, particularly in rural regions.

Opportunities

In addition, rise in the disposable income in advancing and developed nations and new product launches are further estimated to provide potential opportunities for the growth of the contraceptive devices market in the coming years.

Restraints/Challenges

On the other hand, the increasing risk if infections regarding the use of contraceptive devices and the rising incidences of infertility is further projected to impede the growth of the contraceptive devices market in the targeted period. However, the increase in the number of competitors and dangerous effects involved with contraceptive devices might further challenge the growth of the contraceptive devices market in the near future.

This contraceptive devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contraceptive devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Contraceptive Devices Market

The COVID-19 had a negative impact on the contraceptive devices market. The COVID-19 epidemic has had a significant detrimental influence on the contraceptive devices market. The epidemic has altered people's social and economic circumstances. Due to the restrictions on people seeing their doctors without an emergency during the lockdown, the contraception market experienced low demand during the early stages of a pandemic.

Recent Development

  • In January, 2021, In the United States, Teva Pharmaceuticals announced the generic version of NuvaRing (etonogestrel and ethinyl estradiol) Vaginal Ring. Due to the introduction of such vaginal rings, the market for vaginal rings as contraceptive devices is likely to rise.

Global Contraceptive Devices Market Scope and Market Size

The contraceptive devices market is segmented on the basis of product type, technology and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Male Contraceptive Devices
  • Female Contraceptive Devices

On the basis of product type, the contraceptive devices market is segmented into male contraceptive devices and female contraceptive devices. Male contraceptive devices are further sub segmented into condoms. Female contraceptive devices are further sub segmented into intrauterine devices, female condoms, vaginal rings, diaphragms and sponges, sub-dermal implants and others.

Technology

  • Hormonal Contraceptives
  • Barrier Contraceptives

On the basis technology, the contraceptive devices market is segmented into hormonal contraceptives and barrier contraceptives.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel
  • NGOs, Others

On the basis of distribution channel, the contraceptive devices market is segmented into hospital pharmacy, retail pharmacy, clinics, online channel, public channel and NGOs, and others.

Contraceptive Devices Market Regional Analysis/Insights

The contraceptive devices market is analysed and market size insights and trends are provided by country, product type, technology and distribution channel as referenced above.

The countries covered in the contraceptive devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the contraceptive devices market due to the rise in the incidence of STDs. Furthermore, the increase in the adoption rate of contraceptive devices will further boost the growth of the contraceptive devices market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the contraceptive devices market due to the growing awareness. Moreover, the rise in the initiatives taken by the government is further anticipated to propel the growth of the contraceptive devices market in the region during the forecast period in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The contraceptive devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contraceptive devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contraceptive devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Contraceptive Devices Market Share Analysis

The contraceptive devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to contraceptive devices market.

Some of the major players operating in the contraceptive devices market are:

  • Bayer AG (Germany)
  • Pfizer Inc. (US)
  • Janssen Global Services, LLC (US)
  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Merck Sharp & Dohme Corp. (US)
  • Mylan N.V. (US)
  • Reckitt Benckiser Group plc. (UK)
  • Veru Inc. (US)
  • Medisafe Distribution Inc. (Canada)
  • CooperSurgical, Inc. (US)
  • Devex (US)
  • Mayer Laboratories, Inc. (US)
  • Allergan plc (Ireland)
  • Agile Therapeutics (US)
  • HLL Lifecare (India)
  • ANSELL LTD (Australia)
  • Mankind Pharma (India)
  • TTK HealthCare (India)
  • Boehringer Ingelheim International GmbH. (Austria)
  • V-Care Pharma Pvt. Ltd. (India)
  • VARDHAMAN LIFECARE PVT LTD (India)
  • Cipla Inc. (US)


SKU-

Why Choose Us


Frequently Asked Questions

The market value for Allergy Diagnostics Market is expected USD 14933.06 million by 2029.
The Contraceptive Devices Market is to grow at a CAGR of 6.50% during the forecast by 2029
The growth of the Contraceptive Devices Market is influenced by a rise in the allowance for contraceptive devices on a regular basis, rising healthcare expenditures, and technical advancements. Furthermore, rising initiatives as well as assistance from various NGOs, an increase in the number of unwanted births, and poor family planning are all driving factors that are boosting the growth of the contraceptive device market.
The major players operating in the Contraceptive Devices Market are Bayer AG (Germany), Pfizer Inc. (US), Janssen Global Services, LLC (US), Teva Pharmaceutical Industries Ltd. (Jerusalem), Merck Sharp & Dohme Corp. (US), Mylan N.V. (US), Reckitt Benckiser Group plc. (UK), Veru Inc. (US), Medisafe Distribution Inc. (Canada), CooperSurgical, Inc. (US), Devex (US), Mayer Laboratories, Inc. (US), Allergan plc (Ireland), Agile Therapeutics (US), HLL Lifecare (India), ANSELL LTD (Australia), Mankind Pharma (India), TTK HealthCare (India), Boehringer Ingelheim International GmbH. (Austria), V-Care Pharma Pvt. Ltd. (India), VARDHAMAN LIFECARE PVT LTD (India), and Cipla Inc. (US).